Endothelial permeability for macromolecules: Mechanistic aspects of pathophysiological modulation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 6, 1997, Pages 1018-1023

  Van Hinsbergh, Victor W M ^a,b  

^a TNO   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Endothelium; Permeability; Phosphorylation

Indexed keywords

ACTIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; CYCLIC AMP; CYCLIC GMP; HISTAMINE; MYOSIN; MYOSIN LIGHT CHAIN KINASE; NITRIC OXIDE; SEROTONIN; VASOPRESSIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SHORT SURVEY; VASCULAR ENDOTHELIUM;

EID: 0030958851     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.6.1018     Document Type: Short Survey

References (61)

1. Palade GE. The microvascular endothelium revisited. In: Simionescu N, Simionescu M, eds. Endothelial Cell Biology in Health and Disease. New York, NY: Plenum Publishing Corp; 1988:3-21.
2. Bundgaard M. The three-dimensional organization of tight junctions in a capillary endothelium revealed by serial-section electron microscopy. J Ultrastruct Res. 1984;88:1-17.
3. Majno G, Palade GE. Studies on inflammation, I: the effect of histamine and serotonin on vascular permeability-an electron microscopic study. J Biophys Biochem Cytol. 1961;11:571-605.
4. Majno G, Shea SM, Leventhal M. Endothelial contraction induced by histamine-type mediators: an electron microscopic study. J Cell Biol. 1969;42:647-672.
5. Wysolmerski RB, Lagunoff D. Involvement of myosin light-chain kinase in endothelial cell retraction. Proc Natl Acad Sci USA. 1990; 87:16-20.
6. Schnittler H-J, Wilke A, Gress T, Suttorp N, Drenckhahn D. Role of actin and myosin in the control of paracellular permeability in pig, rat and human vascular endothelium. J Physiol. 1990;431: 379-401.
7. Garcia JGN, Davis HW, Patterson CE. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol. 1995;163:510-522.
8. Goeckeler ZM, Wysolmerski RB. Myosin light chain kinase-regulated endothelial cell concentration: the relationship between isometric tension, actin polymerization, and myosin phosphorylation. J Cell Biol. 1995:130:613-627.
9. Moy AB, Van Engelenhoven J, Bodmer J, Kamath J, Keese C, Giaever I, Shasby S, Shasby DM. Histamine and thrombin modulate endothelial focal adhesion through centripetal and centrifugal forces. J Clin Invest. 1996;97:1020-1027.
10. Rabiet M-J, Plantier J-L, Rival Y, Genoux Y, Lampugnani M-G, Dejana E. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vase Biol. 1996;16:488-496.
11. Gardner TW, Lesher T, Khin S, Vu C, Barber AJ, Brennan WA. Histamine reduces ZO-1 tight-junction protein expression in cultured retinal microvascular endothelial cells. Biochem J. 1996;320: 717-721.
12. Joris I, Cuénoud HF, Doern GV, Underwood JM, Majno G. Capillary leakage in inflammation: a study by vascular labeling. Am J Pathol. 1990;137:1353-1363.
13. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995:146:1029-1039.
14. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestrations induced by vascular endothelial growth factor. J Cell Sci. 1995:108:2369-2379.
15. Dejana E. Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest. 1996;98: 1949-1953.
16. Cuénoud HF, Joris I, Langer RS, Majno G. Focal arteriolar insudation: a response of arterioles to chronic nonspecific irritation. Am J Pathol. 1987; 127:592-604.
17. Stemerman MB. Effects of moderate hypercholesterolemia on rabbit endothelium. Arteriosclerosis. 1981;l:25-32.
18. Slender S, Hjelms E. In vivo transfer of cholesterol from plasma into human aortic tissue. Scand J Clin Lab Invest. 1987;47(suppl 186): 21-29.
19. Chuang FT, Cheng HJ, Lin SJ, Jan KM, Lee MML, Chien S. Macromolecular transport across arterial and venous endothelium in rats: studies with Evans blue-albumin and horseradish peroxidase. Arteriosclerosis. 1990;10:188-197.
20. Huang AL, Jan KM, Chien S. Role of intercellular junctions in the passage of horseradish peroxidase across aortic endothelium. Lab Invest. 1992;67:201-209.
21. 2-adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endolhelial gap formation. Am J Physiol. 1994;266:L461-L468.
22. Garcia JGN, Pavalko FM, Patterson CE. Vascular endothelial cell activation and permeability responses to thrombin. Blood Coagulation Fibrinol. 1995;6:609-626.
23. Wysolmerski RB, Lagunoff D. Regulation of permeabilized endothelial cell retraction by myosin phosphorylation. Am J Physiol. 1991; 261:C32-C40.
24. Draijer R, Atsma DE, van der Laarse A, van Hinsbergh VWM. cGMP and nitric oxide modulate thrombin-induced endothelial permeability: regulation via different pathways in human aortic and umbilical vein endothelial cells. Circ Res. 1995;76:199-208.
25. Curry FE. Modulation of venular microvessel permeability by calcium influx into endothelial cells. FASEB J. 1992;6:2456-2466.
26. Gallagher PJ, Garcia JGN, Herring BP. Expression of a novel myosin light chain kinase in embryonic tissues and cultured cells. J Biol Chem. 1995;270:29090-29095.
27. Gallagher PJ, Hou L, McMurtry I, Jin N, Morris K, Walker D, Pavalko F. Embryonic MLCK role in vascular smooth muscle proliferation and migration. J Vase Res. 1996;22(suppl I):28. Abstract.
28. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem. 1996:271:20246-20249.
29. Chrzanowska-Wodnicka M, Burridge K. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol. 1996;133:1403-1415.
30. Nobes CD, Hall A. Rho, Rac and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 1995;81:53-62.
31. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature. 1994;372:231-236.
32. Verin AD, Patterson CE, Day MA, Garcia JGN. Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am J Physiol. 1995;269:L99-L108.
33. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 1996;273:245-248.
34. Lynch JL, Ferro TJ, Blumenstock FA, Brockenauer AM, Malik AB. Increased endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest. 1990;85:1991-1998.
35. 77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers. J Cell Physiol. 1992;153:62-75.
36. Bussolino F, Silvagno F, Garbarino G, Costamagna C, Sanavio F, Arese M, Soldi R, Aglietta M, Pescarmona G, Camussi G, Bosia A. Human endothelial cells are targets for platelet-activating factor (PAF). J Biol Chem. 1994;269:2877-2886.
37. Yamada Y, Furumichi T, Furui H, Yokoi T, Ito T, Yamauchi K, Yokota M, Hayashi H, Saito H. Roles of calcium, cyclic nucleotides and protein kinase C in regulation of endothelial permeability. Arteriosclerosis. 1990; 10:410-420.
38. Nagpala PG, Malik AB, Vuong PT, Lum H. Protein kinase C beta 1 overexpression augments phorbol ester-induced increase in endothelial permeability. J Cell Physiol. 1996; 166:249-255.
39. Del Maschio A, Zanetti A, Corada M, Rival Y, Ruco L, Lampugnani MG, Dejana E. Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol. 1996;135:497-510.
40. Grega GJ, Persson CGA, Svensjö E. Endothelial cell reactions to inflammatory mediators assessed in vivo by fluid and solute flux analysis. In: Ryan US, ed. Endothelial Cells. Boca Raton, Fla: CRC Press Ine; 1988;III:103-119.
41. Shepro D, Alexander JS, Anner H, Atwell A, et al. Endothelial cells, inflammatory edema and the microvascular barrier: comments by a "free radical." Microvasc Res. 1988;35:247-264.
42. Stelzner TJ, Weil JV, O'Brien RF. Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties. J Cell Physiol. 1989;139:157-166.
43. Carson MR, Shasby SS, Shasby DM. Histamine and inositol phosphate accumulation in endothelium: cAMP and a G protein. Am J Physiol. 1989;257:L259-L264.
44. Langeler EG, van Hinsbergh VWM. Norepinephrine and iloprost improve barrier function of human endothelial cell monolayers: role of cAMP. Am J Physiol. 1991;260:C1052-C1059.
45. Moy AB, Shasby SS, Scott BD, Shasby DM. The effect of histamine and cyclic adenosine monophosphate on myosin light chain phosphorylation in human umbilical vein endothelial cells. J Clin Invest. 1993;92:1198-1206.
46. 2+]i and permeability in microvessels exposed to ATP. Am J Physiol. 1993;265:H1019-H1023.
47. Granger DN, Korthuis RJ. Physiological mechanisms of postischemic tissue injury. Annu Rev Physiol. 1995;57:311-332.
48. Lo SK, Everitt J, Gu J, Malik A. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J Clin Invest. 1992;89:981-988.
49. Warren JB, Wilson AJ, Loi RK, Coughlan ML. Opposing roles of cyclic AMP in the vascular control of edema formation. FASEB J. 1993;7:1394-1400.
50. Zimmerman RS, Trippodo NC, MacPhee AA, Martinez AJ, Barbee RW. High-dose atrial natriuretic factor enhances albumin escape from the systemic but not the pulmonary circulation. Circ Res. 1990;67:461-468.
51. Lofton CE, Baron DA, Heffner JE, Currie MG, Newman WH. Atrial natriuretic peptide inhibits oxidant-induced increases in endothelial permeability. J KM Cell Cardiol. 1991;23:919-927.
52. Meyer DJ, Huxley VH. Capillary hydraulic conductivity is elevated by cGMP-dependent vasodilators. Circ Res. 1992;70:382-391.
53. Baron DA, Lofton CE, Newman WH, Currie MG. Atriopeptin inhibition of thrombin-mediated changes in the morphology and permeability of endothelial monolayers. Proc Natl Acad Sci USA. 1989;86: 3394-3398.
54. Suttorp N, Hippenstiel S, Fuhrmann M, Krüll, Podsuweit T. Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability. Am J Physiol. 1996;270:C778-C785.
55. Draijer R, Vaandrager AB, Nolle C, de Jonge HR, Walter U, van Hinsbergh VWM. Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ Res. 1995;77:897-905.
56. MacMillan-Crow LA, Murphy-Ullrich JE, Lincoln TM. Identification and possible localization of cGMP-dependent protein kinase in bovine aortic endothelial cells. Biochem Biophys Res Commun. 1994;201:531-537.
57. Joyce NC, DeCamilli P, Lohmann SM, Walter U. cGMP-dependent protein kinase is present in high concentrations in contractile cells of the kidney vasculature. J Cyclic Nucl Prot Phosphor Res. 1986:11:191-198.
58. Buga GM, Griscavage JM, Rogers NE, Ignarro LJ. Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res. 1993:73:808-812.
59. Suttorp N, Weber U, Welsch T, Schudt C. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest. 1993:91:1421-1428.
60. Yuan Y, Granger HJ, Zawieja DC, DeFily DV, Chilian WM. Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am J Physiol. 1993;264:H1734-H1739.
61. Rodt SA, Reed RK, Ljungstrom M, Gustafsson TO, Rubin K. The anti-inflammatory agent α-trinositol exerts its edema-preventing effects through modulation of β1 integrin function. Circ Res. 1994; 75:942-948.